Continuous Enzyme Evolution – solving bottlenecks in enzyme engineering to desig...
Continuous Enzyme Evolution – solving bottlenecks in enzyme engineering to design next-generation biocatalysts
Directed evolution has revolutionized the application of enzymes in industrial settings by allowing users to tailor the properties and activities of biocatalysts to their needs. But classic directed evolution is notoriously labor-...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CTQ2016-79138-R
VMUTATE: UNA PLATAFORMA PARA LA INGENIERIA DE ENZIMAS
174K€
Cerrado
PGC2018-102192-B-I00
EVOLUCION COMPUTACIONAL DE ENZIMAS MEDIANTE LA EXPLORACION D...
119K€
Cerrado
BIO2015-66426-R
INGENIERIA Y EVOLUCION DE ENZIMAS DE NOVO CON ACTIVIDADES NO...
399K€
Cerrado
BiocatCodeExpander
Genetic code expansion for biocatalysis and enzyme engineeri...
3M€
Cerrado
OptiPlex
Commercial feasibility of a cell-free reactor setup for opt...
150K€
Cerrado
BIO2016-79106-R
EVOLUCION DIRIGIDA Y COMPUTACIONAL DE LIGNINASAS
284K€
Cerrado
Información proyecto ContiZymes
Duración del proyecto: 64 meses
Fecha Inicio: 2023-12-18
Fecha Fin: 2029-04-30
Descripción del proyecto
Directed evolution has revolutionized the application of enzymes in industrial settings by allowing users to tailor the properties and activities of biocatalysts to their needs. But classic directed evolution is notoriously labor- and time-intensive, as it manually stages mutation, selection, and amplification cycles. In contrast, continuous evolution (CE) approaches aim to achieve these steps within a replicating organism, making it possible to engineer efficient enzymes in a matter of days rather than months or years. Unfortunately, current CE approaches are typically applicable only to model enzymes with little industrial value.
To unleash the full potential of CE, we will develop a scalable, low-tech CE platform, which is readily applicable to biocatalysts that provide value-added products. Toward this end, we will merge a versatile selection system we recently developed with strategies to diversify the genes of targeted enzymes in vivo and an autonomous setup to grow bacterial populations continuously. Combined the resulting CE-platform will enable us to engineer biocatalysts along many and long evolutionary trajectories. Moreover, analyzing the fate of these populations by sequencing will allow us to map the sequence-structure-function relationships of these biocatalysts. Based on the systematic datasets generated in these efforts, we will train machine-learning (ML)-models to predict functional sequences. Lastly, in a ML-directed CE approach, we will establish a design-build-test-learn cycle to improve models and guide CEs toward promising, but otherwise inaccessible sequence spaces.
Overall, ContiZymes will overcome unaddressed challenges associated with the application of biocatalysts that promote sought-after C-C, C-halogen, and C-N-bond forming reactions. We will not only engineer these enzymes at an unprecedented rate and scale, but also map their fitness landscapes and take a critical step toward the on-demand design of next-generation biocatalyst